Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
Frequently asked questions
What sector does Demant A/S (DEMANT) operate in?
Demant A/S belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Demant A/S (DEMANT) current stock price?
As of the latest data, Demant A/S stock price is DKK 292.00, with a previous close of DKK 289.60. Demant A/S gained DKK 2.40 in the last trading session, representing a 0.83% increase.
What is Demant A/S (DEMANT) current market capitalization?
Demant A/S market cap is approximately 61.58 billion.
What is Demant A/S (DEMANT) Earnings Per Share (EPS)?
The trailing EPS is DKK 11.48, and the forward EPS is DKK 15.33.
What is Demant A/S (DEMANT) Price-to-Earnings (P/E) ratio?
Demant A/S current P/E ratio is 25.44, with a forward P/E of 19.04.
Does Demant A/S (DEMANT) pay dividends?
No. Demant A/S does not pay a dividend.
When is Demant A/S (DEMANT) next earnings report?
Demant A/S is expected to release its next earnings report on June 30, 2026.
What is Demant A/S (DEMANT) beta (volatility) score?
Demant A/S has a beta of 0.758, indicating lower volatility than the overall market.
